Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Aykut Ozdarendeli"'
Autor:
Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, Ilhami Celik, Sukran Kose, Sila Akhan, Emin Halis Akalin, Aykut Ozdarendeli, Serhat Unal, Ihsan Ates, Ates Kara
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
This study- a secondary analysis of data from a randomized, observer-blinded, non-inferiority study among volunteers between 18–55 y old in Türkiye- evaluated the impact of previous SARS-CoV-2 infection before the first dose of inactive TURKOVAC o
Externí odkaz:
https://doaj.org/article/99e01bd476994f92ba56843b38725bcf
Autor:
Tarlan Mamedov, Damla Yuksel, Irem Gurbuzaslan, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Shaikh Terkis Islam Pavel, Hazel Yetiskin, Busra Kaplan, Muhammet Ali Uygut, Gulnara Hasanova
Publikováno v:
Frontiers in Plant Science, Vol 14 (2023)
SARS-CoV-2, the virus responsible for the COVID-19 pandemic, belongs to the betacoronavirus genus. This virus has a high mutation rate, which rapidly evolves into new variants with different properties, such as increased transmissibility or immune ev
Externí odkaz:
https://doaj.org/article/b8b6e9825927479193f7e1306f53e7b5
Autor:
Tarlan Mamedov, Damla Yuksel, Irem Gurbuzaslan, Merve Ilgin, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Shaikh Terkis Islam Pavel, Hazel Yetiskin, Busra Kaplan, Muhammet Ali Uygut, Gulnara Hasanova
Publikováno v:
Frontiers in Plant Science, Vol 14 (2023)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel and highly pathogenic coronavirus that caused an outbreak in Wuhan City, China, in 2019 and then spread rapidly throughout the world. Although several coronavirus disease 2019 (C
Externí odkaz:
https://doaj.org/article/b65b2844db484b7b9d3a4d6281258656
Autor:
Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan, Muhammet Ali Uygut, Ahmet Furkan Aslan, Adnan Bayram, Mumtaz Mazicioglu, Gamze Kalin Unuvar, Zeynep Ture Yuce, Gunsu Aydin, Refika Kamuran Kaya, Ihsan Ates, Ates Kara, Aykut Ozdarendeli
Publikováno v:
Vaccines, Vol 12, Iss 2, p 140 (2024)
Vaccine-induced immunity wanes over time and warrants booster doses. We investigated the long-term (32 weeks) immunogenicity and safety of a third, homologous, open-label booster dose of TURKOVAC, administered 12 weeks after completion of the primary
Externí odkaz:
https://doaj.org/article/4c74fde40dfc40e3a45a1fce48df4d77
Autor:
Ahmet Omma, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Güven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ates Kara, Ihsan Ates
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after Co
Externí odkaz:
https://doaj.org/article/8c21a7499126460eb2a45f3715e4845c
Autor:
Aykut Ozdarendeli
Publikováno v:
Diagnostics, Vol 13, Iss 16, p 2708 (2023)
Crimean–Congo hemorrhagic fever virus (CCHFV), a member of the Nairoviridae family and Bunyavirales order, is transmitted to humans via tick bites or contact with the blood of infected animals. It can cause severe symptoms, including hemorrhagic fe
Externí odkaz:
https://doaj.org/article/6c47d2461c9744e2bbf9f82d34378878
Autor:
Ihsan Ates, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Guven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ahmet Omma, Ates Kara
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1234 (2023)
The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT049799
Externí odkaz:
https://doaj.org/article/de676a2951d24c999afea7276d33f31e
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08161- (2021)
Crimean–Congo hemorrhagic fever (CCHF) is an emerging zoonotic infectious disease caused by Crimean–Congo hemorrhagic fever virus (CCHFV). The first clinical CCHF infection was described in 1944 in the Crimean Peninsula, exclusively in humans, wi
Externí odkaz:
https://doaj.org/article/aaf48377b19847e5803440c66f272817
Autor:
Mine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, Orhan Yildiz, Ilhami Celik, Hamdi Levent Doganay, Sukran Kose, Sila Akhan, Emin Halis Akalin, Zafer Sezer, Aykut Ozdarendeli, Serhat Unal, on behalf of the TURKOVAC Study Group
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1865 (2022)
We present the interim results of the efficacy, immunogenicity, and safety of the two-dose schedules of TURKOVAC versus CoronaVac. This was a randomized, observer-blinded, non-inferiority trial (NCT04942405). Volunteers were 18–55 years old and ran
Externí odkaz:
https://doaj.org/article/439a76f936ab4b1a84e0b1a3d91c8b7c
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 11, p e0008834 (2020)
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus in the Nairoviridae family within the Bunyavirales order of viruses. Crimean-Congo hemorrhagic fever (CCHF) is the most widespread among tick-borne human viral diseases. It is endemi
Externí odkaz:
https://doaj.org/article/3b0a93e45f3c460f8317bb572b8effb7